Association of genetic polymorphisms of serum amyloid protein Al with plasma high density lipoproteins cholesterol

National Medical Journal of China

Volumn 90, Issue 26, 2010, Pages 1824-1826

  Xie, Xiang ^a   Ma, Yi Tong ^a   Yang, Yi Ning ^a   Fu, Zhen Yan ^a   Li, Xiao Mei ^a   Ma, Xiang ^a   Huang, Ding ^a   Liu, Fen ^b   Chen, Bang Dang ^b   Xiang, Yang ^a   Huang, Ying ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Gene expression; Lipoproteins, HDL

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SERUM AMYLOID A; SERUM AMYLOID PROTEIN A1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; SAA1 PROTEIN, HUMAN;

AGE; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; GENOTYPE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; ADULT; AGED; ALLELE; ASIAN; BLOOD; FEMALE; GENE FREQUENCY; GENETICS; MALE; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED, 80 AND OVER; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CHOLESTEROL, HDL; FEMALE; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SERUM AMYLOID A PROTEIN;

EID: 84871419412     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2010.26.008     Document Type: Article

References (8)

1. Zhao Y, Zhou S, Heng C K. Impact of serum amyliod A on tissue factor and tissue factor pathway inhibitor expression and activity in endothelial cells. Arterioscler Thromb Vasc Biol, 2007, 27: 1645-1650.
2. Jahangiri A, de Beer M C, Noffsinger V, et al. HDL remodeling during the phase response. Arterioscler Thromb Vasc Biol, 2009, 29: 261-267.
3. Carty C L, Heagerty P, Heckbert S R, et al. Association of genetic variation in serum amyloid-A with cardiovascular disease and interactions with IL6, IL1RN, IL1β and TNF gene in the cardiovascular health study. J Atheroscler Thromb, 2009, 16: 419-430.
4. Lutucuta S, Ballantyne C M, Elgha nnam H, et al. Novel polymorphisms in promoter region of ATP binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy. Circ Res, 2001, 88: 969-973.
5. Kyriakou T, Pontefract D E, Viturro E, et al. Functional polymorphism in ABCA1 influences age of symptom onset in coronary artery disease patients. Hum Mol Genet, 2007, 16: 1412-1422.
6. Shanker J, Perumal G, Rao V S, et al. Genetic studies on the APOA1-C3-A5 gene cluster in Asian Indians with premature coronary artery disease. Lipids Health Dis, 2008, 7:33-57.
7. Dallongeville J, Cottel D, Wagner A, et al. The APOA5 Trp19 allele is associated with metabolic syndrome via its association with plasma triglycerides. BMC Med Genet, 2008, 9:84-92.
8. Kimchi-Sarfaty C, Oh J M, Kim I W, et al. A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science, 2007, 318:1382-1383.